J B Chemicals and Pharmaceuticals Limited has announced a key change in its senior management with the resignation of Mr. Himanshu Ranvah from his position as Vice President-Legal. The pharmaceutical company disclosed this development in compliance with regulatory requirements under SEBI listing obligations.

Resignation Details

Mr. Himanshu Ranvah ceased to be the Vice President-Legal with effect from closing of business hours on February 6, 2026. The company formally communicated this change to BSE Limited through a regulatory filing dated February 7, 2026.

Resignation Letter Highlights

In his resignation letter dated January 23, 2026, addressed to Chief Financial Officer Narayan Saraf, Mr. Ranvah expressed his decision to step down after careful consideration. He acknowledged his tenure with the company as an incredible journey and tremendous learning opportunity that he would cherish forever.

Transition Arrangements

To ensure operational continuity, Mr. Ranvah committed to a smooth handover of his work and responsibilities to Mr. Vishal Chavan. The outgoing Vice President-Legal requested to be relieved at the earliest while ensuring proper knowledge transfer.

Regulatory Compliance

The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in conjunction with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The announcement was signed by Sandeep Phadnis, Vice President – Secretarial & Company Secretary.

J.B. Chemicals & Pharmaceuticals Limited, incorporated in 1976 with CIN L24390GJ1976PLC173077, operates from its corporate office in Mumbai's Prabhadevi area while maintaining its registered office in Ahmedabad, Gujarat.

J B Chemicals and Pharmaceuticals Limited has announced the resignations of two senior management personnel in a regulatory disclosure filed on February 5, 2026. The pharmaceutical company informed the stock exchanges about the departure of key executives from operational and business leadership roles.

Senior Management Changes

The company disclosed that Mr. Kunal Khanna, President – Operations, and Mr. Dilip Singh Rathore, President (India Business), have submitted their resignations. Both executives tendered their resignations on February 5, 2026, with the resignations taking effect from the closing of business hours on March 5, 2026.

Regulatory Compliance

The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement also complies with the SEBI Master Circular bearing reference number SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, which governs disclosures related to changes in senior management personnel.

Transition Timeline

Both resignations provide a one-month transition period, with the executives continuing in their roles until March 5, 2026. This timeline allows the company to manage the transition of responsibilities and ensure operational continuity during the leadership change.

The company secretary, Sandeep Phadnis, Vice President – Secretarial & Company Secretary, signed the regulatory filing on behalf of J.B. Chemicals & Pharmaceuticals Limited. The disclosure was submitted to BSE Limited under the company's scrip code 506943 and stock symbol JBCHEPHEARM.